Close

UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Raising Estimates on aHUS, Margins Oct 21, 2011 12:56PM
Notable 52-Week Highs and Lows of the Day 09/15: (ALXN) (WFM) (ACC) High; (UBS) (PWRD) (CISG) Low Sep 15, 2011 03:28PM
UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Missed a Step-Up; Neutral on Catalysts Jul 22, 2011 10:20AM
UBS Maintains an 'Neutral' on Alexion Pharmaceuticals (ALXN); Adjusting Model for 2Q Developments Jul 8, 2011 10:50AM
UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Raising Price Target on FY2011 Guidance Feb 11, 2011 10:41AM


Jan 7, 2011 08:29AM UBS Downgrades Alexion Pharmaceuticals (ALXN) to Neutral
Oct 18, 2010 01:46PM UBS Maintains a 'Buy' on Alexion Pharma (ALXN); Expect Greater Uptake of Soliris in aHUS
Sep 22, 2010 11:00AM Notable Analyst Rating Changes 09/22: VVUS, BAX, ALXN, DLB Upgraded; ADBE, NOK, PMCS, SOHU Downgraded
Apr 20, 2010 12:10PM UBS Maintains a 'Buy' on Alexion Pharma (ALXN); Raises PT on aHUS opportunity
Apr 23, 2009 10:07AM David Moenning's Daily State of the Markets: 4/23
Feb 9, 2009 10:03AM Notable Analyst Rating Changes 2/9: WYE, PFE, ADBE, CHK, GLW, BIG Upgraded; LEN, PAS, CVX, DOW Downgraded
Oct 23, 2008 10:07AM David Moenning's Daily State of the Markets: 10/23
Jul 29, 2008 10:06AM David Moenning’s Daily State of the Markets: 07/29
Feb 14, 2008 09:45AM David Moenning's Daily State of the Markets: 2/14
Jan 29, 2008 07:30AM UBS Initiates Coverage on Alexion Pharmaceuticals (ALXN) with a Buy